WF
DNA icon

Welch & Forbes’s Ginkgo Bioworks DNA Stock Holding History

Welch & Forbes’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$184K Hold
30,000
– – ﹤0.01% 364
2025
Q4 		$249K Hold
30,000
– – ﹤0.01% 348
2025
Q3 		$437K Hold
30,000
– – 0.01% 288
2025
Q2 		$338K Hold
30,000
– – ﹤0.01% 311
2025
Q1 		$171K Hold
30,000
– – ﹤0.01% 367
2024
Q4 		$295K Sell
30,000
-26,750
-47% -$229K ﹤0.01% 327
2024
Q3 		$463K Sell
56,750
-125,000
-69% -$1.25M 0.01% 297
2024
Q2 		$2.24M Buy
181,750
+6,750
+4% +$201K 0.03% 177
2024
Q1 		$8.12M Hold
175,000
– – 0.11% 105
2023
Q4 		$11.8M Hold
175,000
– – 0.18% 92
2023
Q3 		$12.7M Buy
+175,000
New +$14M 0.21% 91

Other funds holding DNA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return